Clinical trial
The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease…
NCT00255086 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00255086 |
|---|---|
| Title | The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients |
| Official title | The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients: A Randomized, Placebo-Controlled, 52-Week Clinical Trial |
| Lead sponsor | Stanford University, Other |
| Collaborators | Palo Alto Veterans Institute for Research Forest Laboratories Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Memantine, Placebo pill |
| Enrollment | 17 |
| Start date | May 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Feb 1, 2010 |
| First posted | Nov 17, 2005 |
| Last update posted | Apr 7, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: